Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
International Journal of Molecular Sciences|January 11, 2024
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder CancerTouseef Ahmad Qureshi, Xingyu Chen, Yibin Xie, et al.Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.Biochemistry|January 28, 2009
Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer propertiesCaroli Genis, Katherine H Sippel, Nicolette Case, et al.Journal of the National Medical Association|July 16, 2004
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancerCharles J Rosser, Deborah A Kuban, Sang-Joon Lee, et al.Plos One|June 5, 2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansionEvan Gomes-Giacoia, Makito Miyake, Steve Goodison, et al.Cancer Gene Therapy|July 24, 2002
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancerMotoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, et al.Neoplasia (New York, N.Y.)|October 1, 2016
CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder CancerMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.Oncology Letters|September 12, 2012
The use of zoledronic acid in Japanese men with stage D2 prostate cancerKogenta Nakamura, Yoshiaki Yamada, Charles J Rosser, et al.Oncotarget|February 20, 2016
Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2Melissa E Ho, Sue-Ing Quek, Lawrence D True, et al.Journal of Translational Medicine|February 7, 2020
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse modelHideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, et al.Pageof 17